Bill Commons

CA SB 1047

enacted

Neurodegenerative disease registry program.

California · 2025-2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did CA SB 1047 pass?

Yes. CA SB 1047 has been enacted into law. Latest recorded action (2026-09-30): Chaptered by Secretary of State. Chapter 1000, Statutes of 2026.

What is CA SB 1047 about?

Existing law, until January 1, 2028, and to the extent funds are made available for these purposes, requires the State Department of Public Health to establish a system for the collection of information determining the incidence and prevalence of neurodegenerative diseases, including, but not limited to, amyotrophic lateral sclerosis (ALS) , also known as Lou Gehrig's disease. Existing law requires a hospital, facility, physician and surgeon, or other health care provider diagnosing or providing treatment to a patient for a neurodegenerative disease to report each case of a neurodegenerative disease to the department, as prescribed. Existing law requires the department to designate the specified neurodegenerative diseases required to be reported in the state or any part of the state. Existing law specifies that for this purpose, "neurodegenerative disease" may include, but need not be limited to, Alzheimer's disease, multiple sclerosis, and Huntington's disease. This bill would require the department to establish a system for the collection of information determining the incidence and prevalence of frontotemporal degeneration (FTD) . This bill would specify that "neurodegenerative disease" may also include other dementias. The bill would extend the requirements of these provisions until January 1, 2032.

Who sponsors CA SB 1047?

Niello is the primary sponsor of CA SB 1047, joined by 8 cosponsors.

Description

Existing law, until January 1, 2028, and to the extent funds are made available for these purposes, requires the State Department of Public Health to establish a system for the collection of information determining the incidence and prevalence of neurodegenerative diseases, including, but not limited to, amyotrophic lateral sclerosis (ALS) , also known as Lou Gehrig's disease. Existing law requires a hospital, facility, physician and surgeon, or other health care provider diagnosing or providing treatment to a patient for a neurodegenerative disease to report each case of a neurodegenerative disease to the department, as prescribed. Existing law requires the department to designate the specified neurodegenerative diseases required to be reported in the state or any part of the state. Existing law specifies that for this purpose, "neurodegenerative disease" may include, but need not be limited to, Alzheimer's disease, multiple sclerosis, and Huntington's disease. This bill would require the department to establish a system for the collection of information determining the incidence and prevalence of frontotemporal degeneration (FTD) . This bill would specify that "neurodegenerative disease" may also include other dementias. The bill would extend the requirements of these provisions until January 1, 2032.

Introduced
2026-02-12
Latest action
2026-09-30 — Chaptered by Secretary of State. Chapter 1000, Statutes of 2026.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Nielloauthor
  • Allenauthor
  • Alvarado-Gilcoauthor
  • Ochoa Boghcoauthor
  • Seyartocoauthor
  • Valladarescoauthor
  • Irwincoauthor
  • Tangipacoauthor
  • Hoovercoauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-09-30

    Chaptered by Secretary of State. Chapter 1000, Statutes of 2026.

    became-law

  2. 2026-09-30

    Approved by the Governor.

    executive-signature

  3. 2026-09-02

    Enrolled and presented to the Governor at 3 p.m.

    executive-receipt

  4. 2026-08-27

    Assembly amendments concurred in. (Ayes 39. Noes 0.) Ordered to engrossing and enrolling.

    amendment-passage,committee-passage,committee-passage-favorable

  5. 2026-08-26

    Ordered to special consent calendar.

  6. 2026-08-24

    Read third time. Passed. Ordered to the Senate.

    passage,reading-1,reading-3

  7. 2026-08-24

    In Senate. Concurrence in Assembly amendments pending.

  8. 2026-08-24

    Read third time. Passed. (Ayes 76. Noes 0. Page 6393.) Ordered to the Senate.

    passage,reading-1,reading-3

  9. 2026-08-19

    Ordered to third reading.

    reading-1,reading-3

  10. 2026-08-19

    Read third time and amended.

    amendment-passage,reading-1,reading-3

  11. 2026-08-13

    Assembly Rule 63 suspended.

  12. 2026-08-13

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  13. 2026-08-13

    From committee: Do pass. (Ayes 15. Noes 0.) (August 13).

    committee-passage,committee-passage-favorable

  14. 2026-07-01

    July 1 set for first hearing. Placed on suspense file.

  15. 2026-06-17

    From committee: Do pass and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 15. Noes 0.) (June 16). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  16. 2026-06-04

    Referred to Com. on HEALTH.

    referral-committee

  17. 2026-05-28

    In Assembly. Read first time. Held at Desk.

    reading-1

  18. 2026-05-28

    Read third time. Passed. (Ayes 39. Noes 0. Page 4525.) Ordered to the Assembly.

    passage,reading-1,reading-3

  19. 2026-05-26

    Ordered to special consent calendar.

  20. 2026-05-18

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  21. 2026-05-14

    From committee: Do pass as amended. (Ayes 7. Noes 0. Page 4262.) (May 14).

    amendment-passage,committee-passage,committee-passage-favorable

  22. 2026-05-14

    Read second time and amended. Ordered to second reading.

    amendment-passage,reading-1,reading-2

  23. 2026-05-08

    Set for hearing May 14.

  24. 2026-04-13

    April 13 hearing: Placed on APPR. suspense file.

  25. 2026-04-10

    Set for hearing April 13.

  26. 2026-04-06

    Read second time and amended. Re-referred to Com. on APPR.

    amendment-passage,reading-1,reading-2,referral-committee

  27. 2026-03-26

    From committee: Do pass as amended and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 11. Noes 0. Page 3690.) (March 25).

    amendment-passage,committee-passage,committee-passage-favorable,referral-committee

  28. 2026-03-11

    Set for hearing March 25.

  29. 2026-02-26

    Referred to Com. on HEALTH.

    referral-committee

  30. 2026-02-13

    From printer. May be acted upon on or after March 15.

  31. 2026-02-12

    Introduced. Read first time. To Com. on RLS. for assignment. To print.

    introduction,reading-1,referral-committee

Versions

  • 02/12/26 - Introduced — 2026-02-12Compare
  • 04/06/26 - Amended Senate — 2026-04-06Compare
  • 05/14/26 - Amended Senate — 2026-05-14Compare
  • 08/19/26 - Amended Assembly — 2026-08-19Compare
  • 08/30/26 - Enrolled — 2026-08-30Compare
  • 09/30/26 - Chaptered — 2026-09-30Compare
  • (document, no version)Compare
  • SB1047Compare

Documents

Votes

  • Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] with the recommendation: To Consent Calendar

    2026-03-25 · pass · 11-0

    Member-level votes (11)
    • Menjivar: yes
    • Gonzalez: yes
    • Pérez: yes
    • Smallwood-Cuevas: yes
    • Rubio: yes
    • Weber Pierson: yes
    • Grove: yes
    • Padilla: yes
    • Durazo: yes
    • Caballero: yes
    • Valladares: yes
  • Placed on suspense file

    2026-04-13 · pass · 7-0

    Member-level votes (7)
    • Dahle: yes
    • Richardson: yes
    • Cervantes: yes
    • Cabaldon: yes
    • Seyarto: yes
    • Wahab: yes
    • Grayson: yes
  • Do pass as amended

    2026-05-14 · pass · 7-0

    Member-level votes (7)
    • Cervantes: yes
    • Seyarto: yes
    • Wahab: yes
    • Cabaldon: yes
    • Dahle: yes
    • Richardson: yes
    • Grayson: yes
  • Special Consent SB1047 Niello et al.

    2026-05-28 · pass · 39-0

    Member-level votes (40)
    • Blakespear: yes
    • Gonzalez: yes
    • Arreguín: yes
    • Wiener: yes
    • Seyarto: yes
    • Wahab: yes
    • Stern: yes
    • Umberg: yes
    • Choi: yes
    • Jones: yes
    • McGuire: yes
    • Grove: yes
    • Valladares: yes
    • Pérez: yes
    • Reyes: yes
    • Padilla: yes
    • Allen: yes
    • Menjivar: yes
    • Weber Pierson: yes
    • Ochoa Bogh: yes
    • Grayson: yes
    • Rubio: yes
    • Niello: yes
    • Smallwood-Cuevas: yes
    • Durazo: yes
    • Hurtado: yes
    • Strickland: yes
    • Cabaldon: yes
    • Limón: yes
    • Ashby: yes
    • McNerney: yes
    • Richardson: yes
    • Laird: yes
    • Cortese: yes
    • Cervantes: yes
    • Caballero: yes
    • Archuleta: yes
    • Becker: yes
    • Alvarado-Gil: yes
    • Dahle: other
  • Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar

    2026-06-16 · pass · 15-0

    Member-level votes (16)
    • Patel: yes
    • Aguiar-Curry: yes
    • Bonta: yes
    • Carrillo: yes
    • Patterson: yes
    • Sharp-Collins: yes
    • Addis: yes
    • Schiavo: yes
    • Caloza: yes
    • Ahrens: yes
    • Celeste Rodriguez: yes
    • Stefani: yes
    • Mark González: yes
    • Chen: yes
    • Sanchez: yes
    • Johnson: other

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-10-03T00:26:35.256964Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=SB 1047. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.